Clinical Trials
- Asthma, Lung
Tezepelumab COPD Exacerbation Study (COURSE)
- Ages40 years - 80 years
- GenderBoth
- Immune System
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
- Lung
Saracatinib (AZD0530) in the Treatment of Patients with Idiopathic Pulmonary Fibrosis
- Ages40 years and older
- GenderBoth
- Lung Cancer
Phase IB/II Trial Of Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
- Lung Cancer
test
- Lung Cancer
Determining Mechanisms of Sensitivity and Resistance to Anti-Cancer Therapy for Advanced Lung Cancer
- Diseases of the Respiratory Systems
Peripheral Blood Profiling to Screen Patients for Lung Cancer or Lung Cancer Recurrence
- Lung Cancer
test
- Lung Cancer
test
- Lung Cancer
test